Ioneer (ASX:INR) has raised US$50 million via an institutional placement to accelerate the development of its 100% owned Rhyolite Ridge Lithium-Boron Project in Nevada.
OncoSil Medical (ASX:OSL) announced early clinical results from Ankara Bilkent City Hospital in Türkiye, demonstrating a potential paradigm shift in the treatment of unresectable locally advanced pancreatic cancer.
First Au (ASX:FAU) announced a major strategic pivot, transitioning to a simplified, Australia-centric business model to improve market relevance and valuation clarity.
Well, grab a champagne flute and a slice of avocado toast, because the Australian Taxation Office has graced us with its annual Taxation Statistics report for the 2022–23 year.
And what a delightful read it is for anyone living in a post-code that isn't 2027 (Darling Point, Sydney).
Australia’s latest CPI shows inflation climbed to 3.8% in December, stronger than markets expected.
Australia’s "Big Four" banks are now unanimous in forecasting a 0.25% interest rate hike on Feb. 3, following a surge in headline inflation to 3.8%.
The Australian Bureau of Statistics has reported that the consumer price index rose 3.8% in the 12 months to December 2025.
Mayne Pharma (ASX:MYX) is set to return to the Supreme Court of New South Wales next month to recover legal costs from its failed $672 million takeover by US-based Cosette Pharmaceuticals.
ResMed's (ASX:RMD) revenue for the second quarter to December 2025 climbed 11% to $1.4 billion, reflecting a 9% increase on a constant currency basis.
Diversified United Investment (ASX:DUI) has entered into a formal implementation deed to merge with Australian United Investment (ASX:AUI).